Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II study, BTCRC-GU15-023.
Journal for immunotherapy of cancer（2023）
摘要
NCT02891161.
更多查看译文
关键词
Immunotherapy,Radioimmunotherapy,Urinary Bladder Neoplasms
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要